How many employees work at Vaxcyte?
Vaxcyte, Inc. (PCVX) has approximately 500 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Vaxcyte's total headcount has grown 132.2% from 215 employees in 2023 to 500 in 2026.
Data source: Revelio LabsCoverage: Global workforce, 2023–2026Published July 2026
Is Vaxcyte hiring right now?
Yes, Vaxcyte is actively hiring. Vaxcyte had 74 active job postings in 2026, a 26.0% increase from 2025 — see job openings & hiring trends.
About Vaxcyte's Workforce
Vaxcyte, Inc. (PCVX) is a Pharmaceuticals company that employs 500 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 2013, the company is headquartered in San Carlos, California and trades on the NASDAQ.
Vaxcyte's workforce has grown 132.2% from 2023 to 2026, and it is up 14.5% year over year in 2026. Its staff is concentrated in the United States (89.8%), with Switzerland accounting for 9.3% and Canada 0.6%, and Canada, its fastest-growing location, rising 100.0%.
Vaxcyte's largest groups by headcount are Finance and Operations (53.6%), Engineering (23.4%), and Sales and Marketing (23.1%), with Sales and Marketing the fastest-growing segment at 10.4%. The average tenure is 2.2 years, and the typical pay is $184,057 overall, with regional medians of $156,000 in Northern America and $194,000 in Western Europe.
Vaxcyte's active job postings rose 26.0% in 2026 to 74, with postings per month increasing from 18 in 2023 to 28 in 2026. Employee sentiment remains neutral but improving.
Sourced from Revelio Labs workforce data.
As of March 2026
Vaxcyte
workforce metrics
Headcount
500
14.5% YoY
Avg. Salary
$184.1k
2.8% YoY
Tenure
2.2yr
0.3yr YoY
Growth Rate
14.5%
22.9pts YoY
Hiring Rate
Attrition Rate
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Vaxcyte. Compare to peers, export the dataset, and access the full quarterly history.
- Vaxcyte had 500 employees in 2026, a 14.5% increase (+67) from 2025.
- Vaxcyte had 469 employees in 2025, a 15.8% increase (+69) from 2024.
- Vaxcyte had 400 employees in 2024, a 43.8% increase (+144) from 2023.
- Vaxcyte had 256 employees in 2023, a 38.8% increase (+83) from 2022.
Vaxcyte's total workforce has grown from 215 employees in 2023 to 500 in 2026.
Vaxcyte, Inc. — quarterly employee count (2023–2026)
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 500 | +67 | +14.5% |
| 2025 | Q4 | 469 | +69 | +15.8% |
| 2025 | Q3 | 454 | +90 | +22.0% |
| 2025 | Q2 | 454 | +116 | +29.1% |
| 2025 | Q1 | 433 | +136 | +37.3% |
| 2024 | Q4 | 400 | +144 | +43.8% |
| 2024 | Q3 | 364 | +127 | +42.5% |
| 2024 | Q2 | 338 | +123 | +44.4% |
| 2024 | Q1 | 297 | +105 | +42.6% |
| 2023 | Q4 | 256 | +83 | +38.8% |
| 2023 | Q3 | 237 | +72 | +35.7% |
| 2023 | Q2 | 215 | +66 | +36.7% |
Want to see Vaxcyte's complete headcount history back to 2008, including quarterly breakdowns?
The United States accounts for the largest share of Vaxcyte's global workforce with approximately 90% of total employees, followed by Switzerland and Canada. Vaxcyte's headcount in Canada is growing fastest among its major locations, up 100.0% year over year in 2026.
Vaxcyte employees by country — 2026
| Country | Employees | % of Total | YoY % |
|---|---|---|---|
| United States | 428 | 89.8% | +2.8% |
| Switzerland | 44 | 9.3% | +27.0% |
| Canada | 3 | 0.6% | +100.0% |
| United Kingdom | 1 | 0.3% | -62.3% |
Drill into city-level data, hiring trends by region and historic geographic shifts
Vaxcyte's largest employee groups are Finance and Operations (53.6%), Engineering (23.4%), and Sales and Marketing (23.1%).
Vaxcyte employees by department — 2026
| Department | Employees | % of Total | YoY % |
|---|---|---|---|
| Finance and Operations | 271 | 53.6% | +7.6% |
| Engineering | 118 | 23.4% | +2.3% |
| Sales and Marketing | 117 | 23.1% | +10.4% |
Compare Vaxcyte's department mix to industry peers.
Vaxcyte's average employee salary is $184,057 globally. Employees in Western Europe receive the highest compensation. Pay is lowest in Northern America, at a median of $156,000.
Vaxcyte median employee salary by region — 2026 (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $194,000 |
| Northern America | $156,000 |
Unlock salary by role, level, and city — and compare to Vaxcyte's industry peers.
- Vaxcyte had 74 active job postings in 2026, a 26.0% increase (+39) from 2025.
- Vaxcyte had 35 active job postings in 2025, a 61.4% decline (-31) from 2024.
- Vaxcyte had 66 active job postings in 2024, a 61.4% increase (+31) from 2023.
- Vaxcyte had 35 active job postings in 2023, a 2.8% decline from 2022.
- Hiring velocity in 2026: 28 new roles/month, up from 16 in 2025 and 20 in 2024. New metric
Vaxcyte's hiring is accelerating: active job postings rose 26.0% in 2026 to 74, with new postings per month climbing from 18 in 2023 to 28 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Revelio Labs tracks employee sentiment across Vaxcyte's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Similar Pharmaceuticals Companies by Employee Count
- How fast is Vaxcyte growing?
- In 2026, Vaxcyte's headcount grew 14.5% to 500 employees, up from 433 in 2025.
- Where are Vaxcyte employees located?
- Most Vaxcyte employees are based in the United States (89.8% of headcount), followed by Switzerland and Canada.
- What is the average salary at Vaxcyte?
- The average employee salary at Vaxcyte is approximately $184.1k per year.
- How many people does Vaxcyte hire per year?
- In 2026, Vaxcyte opened roughly 336 new roles — about 28 per month.
- When was Vaxcyte founded and where is it headquartered?
- Vaxcyte was founded in 2013 and is headquartered in San Carlos, California.
See something that doesn't look right? Reach out and our team will review it.